Our marker-based primary screens found Signal Transducer and Activator of Transcription 2 knockdown (STAT2 KD) regulates lipid-rich, disease-associated, antigen-presenting and interferon-responsive states in the iTF-MG model. This evidence concerns the gene STAT2 and myasthenia gravis.